Treatment of imipramine-resistant recurrent depression, III: Efficacy of monoamine oxidase inhibitors.
Michael E. Thase(Veterans Health Administration), David J. Kupfer(University of Pittsburgh), Erica Frank(University of British Columbia), T Hamer, Alan G. Mallinger
PubMed
January 1, 1992
Cited by 114
Related Papers
The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression
|Biological Psychiatry|2003|3.9k
A Comparison of Nefazodone, the Cognitive Behavioral-Analysis System of Psychotherapy, and Their Combination for the Treatment of Chronic Depression
|New England Journal of Medicine|2000|1.3k
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design
|Controlled Clinical Trials|2004|1.1k
Frontiers of cognitive therapy
|General Hospital Psychiatry|1997|1.1k